MUMBAI, India, Sept. 28 -- Kerrie Setiawan and Adam Watkinson, both of Australia, have developed a transdermal delivery system. Application No. 1570/KOLNP/2010 was filed on May 4, and published on Sept. 17.
The application has been assigned to Acrux DDS Pty. Ltd., Victoria, Australia.
According to the abstract released by the Intellectual Property India: "A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and polyethylene glycol (PEG) of average molecular weight no more than 300."
The international filing date for the patent was Oct. 31, 2008, under International Application No. PCT/AU2008/001614.
ACR Price at posting:
$2.28 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)